文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝细胞癌：流行病学、筛查和肝储备功能评估。

Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.

机构信息

Division of Hepatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, U.S.A.

出版信息

Curr Oncol. 2020 Nov;27(Suppl 3):S138-S143. doi: 10.3747/co.27.7181. Epub 2020 Nov 1.

DOI:10.3747/co.27.7181
PMID:33343207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7739519/
Abstract

Hepatocellular carcinoma is a leading cause of cancer-related mortality worldwide. This review summarizes the epidemiology and causes of the disease, and the roles of screening and surveillance for early tumour detection. It also highlights the important role of assessment of hepatic reserve in consideration of appropriate staging and treatment.

摘要

肝细胞癌是全球癌症相关死亡的主要原因。本文综述了该病的流行病学和病因，以及筛查和监测在早期肿瘤检测中的作用。本文还强调了评估肝脏储备在适当分期和治疗中的重要作用。

相似文献

[1]
Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve.

Curr Oncol. 2020-11

[2]
Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment.

Curr Probl Diagn Radiol. 2015

[3]
Screening and surveillance for hepatocellular carcinoma: perspective of a new era?

Expert Rev Anticancer Ther. 2016-12

[4]
Hepatocellular carcinoma: diagnostics and screening.

J Eval Clin Pract. 2010-11-30

[5]
Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.

Semin Liver Dis. 2010-2-19

[6]
Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?

Dig Dis Sci. 2019-4

[7]
Hepatocellular carcinoma.

Curr Opin Gastroenterol. 2006-5

[8]
Hepatocellular cancer.

West Indian Med J. 2009-6

[9]
The diagnosis and treatment of hepatocellular carcinoma.

Semin Diagn Pathol. 2017-3

[10]
Surveillance for hepatocellular carcinoma...a hotly debated issue.

Acta Gastroenterol Belg. 2004

引用本文的文献

[1]
Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers.

PeerJ. 2025-7-21

[2]
Diagnostic performance of contrast-enhanced ultrasonography for predicting therapeutic response to radiofrequency ablation in patients with hepatocellular carcinoma: a meta-analysis.

Discov Oncol. 2025-7-1

[3]
Hepatocellular Carcinoma: The Search for an Optimal Screening Test.

Middle East J Dig Dis. 2025-1

[4]
Risk of malignancy in adult patients with congenital heart disease: a clinical practice review.

Cardiovasc Diagn Ther. 2025-2-28

[5]
Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinoma.

J Liq Biopsy. 2023-9-26

[6]
Decoding the Prognostic Significance and Therapeutic Implications of Inflammation-Based Scores in Hepatocellular Carcinoma: A Comprehensive Review.

Cancers (Basel). 2024-7-15

[7]
Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.

Can Liver J. 2022-11-7

[8]
Twelve protections evolved for the brain, and their roles in extending its functional life.

Front Neuroanat. 2023-11-6

[9]
circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis.

Aging (Albany NY). 2023-11-24

[10]
Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.

BMC Cancer. 2023-11-4

本文引用的文献

[1]
Human Virus Transcriptional Regulators.

Cell. 2020-7-9

[2]
Epidemiology of Hepatocellular Carcinoma.

Hepatology. 2021-1

[3]
Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.

Hepatology. 2020-10

[4]
Epidemiology and surveillance for hepatocellular carcinoma: New trends.

J Hepatol. 2020-2

[5]
International trends in hepatocellular carcinoma incidence, 1978-2012.

Int J Cancer. 2020-7-15

[6]
A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Nat Rev Gastroenterol Hepatol. 2019-8-22

[7]
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?

World J Gastroenterol. 2019-8-7

[8]
Correlation between rs738409 polymorphism and hepatocellular carcinoma: a meta-analysis of 10,330 subjects.

Int J Biol Markers. 2019-3-11

[9]
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.

Medicine (Baltimore). 2019-2

[10]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索